Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | ACHE | P22303 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | LPL | P06858 | 1/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.39 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.39 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.39 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.39 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13778727 | 0.85 | TEAD4 (0.52) | ALDH1A1TSHRACHETDP1RAB9A | |
| SCHEMBL12315016 | 0.83 | ALDH1A1 (0.38) | ALDH1A1TSHRMAPT | |
| SCHEMBL2138626 | 0.81 | ALDH1A1 (0.55) | ALDH1A1TSHRACHETDP1RAB9A | |
| SCHEMBL18595403 | 0.79 | ALDH1A1 (0.60) | ALDH1A1TSHRACHETDP1RAB9A | |
| SCHEMBL812498 | 0.78 | ALDH1A1 (0.67) | ALDH1A1TSHRACHETDP1RAB9A | |
| SCHEMBL517128 | 0.78 | ALDH1A1 (0.67) | ALDH1A1TSHRACHETDP1RAB9A | |
| SCHEMBL22083898 | 0.78 | ALDH1A1 (0.67) | ALDH1A1TSHRACHETDP1RAB9A | |
| SCHEMBL15854781 | 0.78 | ALDH1A1 (0.67) | ALDH1A1TSHRACHETDP1RAB9A | |
| SCHEMBL30982133 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TSHRACHETDP1RAB9A | |
| SCHEMBL11835341 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TSHRACHETDP1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116179084-A | High-adhesion pavement marking paint and preparation process thereof | 浙江兄弟路标涂料有限公司 | 2023-05-30 | — | — | CN | claimed |
| US-5401783-A | Adhesion-promoting agents incorporating polyvalent cations | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1995-03-28 | — | — | US | claimed |
| US-5270351-A | Adhesion-promoting agents incorporating polyvalent cations | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1993-12-14 | — | — | US | claimed |
| EP-0081972-B1 | TWO-PART, TWO-TIER CURE ADHESIVE COMPOSITION | LOCTITE CORPORATION (US) | 1986-06-25 | — | — | EP | claimed |
| CN-116179084-A | High-adhesion pavement marking paint and preparation process thereof | 浙江兄弟路标涂料有限公司 | 2023-05-30 | — | — | CN | disclosed |
| EP-3019141-B1 | HARDENABLE DENTAL COMPOSITION CONTAINING A MIXTURE OF AGGLOMERATED AND AGGREGATED NANOPARTICLES, KIT OF PARTS AND USE THEREOF | 3M INNOVATIVE PROPERTIES CO (US) | 2022-08-31 | — | — | EP | disclosed |
| US-20180072691-A1 | METHODS OF PRODUCING AN HIV MATURATION INHIBITOR | BRISTOL-MYERS SQUIBB COMPANY | 2018-03-15 | — | — | US | disclosed |
| US-9782329-B2 | Hardenable dental composition containing a mixture of agglomerated and aggregated nano-particles, kit of parts and use thereof | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2017-10-10 | — | — | US | disclosed |
| US-20160136059-A1 | HARDENABLE DENTAL COMPOSITION CONTAINING A MIXTURE OF AGGLOMERATED AND AGGREGATED NANO-PARTICLES, KIT OF PARTS AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2016-05-19 | — | — | US | disclosed |
| EP-3019141-A1 | HARDENABLE DENTAL COMPOSITION CONTAINING A MIXTURE OF AGGLOMERATED AND AGGREGATED NANO-PARTICLES, KIT OF PARTS AND USE THEREOF | 3M Innovative Properties Company (US) | 2016-05-18 | — | — | EP | disclosed |
| US-9339443-B2 | Dental restorative material based on an antimicrobially active compound | IVOCLAR VIVADENT AG (LI) | 2016-05-17 | — | — | US | disclosed |
| WO-2015173321-A1 | COMPOSITION FOR DYEING KERATIN FIBRES, COMPRISING A PARTICULAR IMIDAZOLE COUPLER AND AN OXIDATION BASE | L'OREAL (FR) | 2015-11-19 | — | — | WO | disclosed |
| WO-1999062460-A1 | PHOTOPOLYMERIZABLE DENTAL COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-12-09 | — | — | WO | disclosed |
| US-5789610-A | Adhesion-promoting agents incorporating polyvalent cations | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1998-08-04 | — | — | US | disclosed |
| US-5554665-A | PHOTO OR THERMAL ACRYLIC POLYMERIZATION | DENTSPLY RESEARCH & DEVELOPMENT CORP. (US) | 1996-09-10 | — | — | US | disclosed |
| US-5444104-A | Dental restorative material based on a polycarbonate dimethacrylate | JENERIC/PENTRON, INC. (US) | 1995-08-22 | — | — | US | disclosed |
| US-5401783-A | Adhesion-promoting agents incorporating polyvalent cations | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1995-03-28 | — | — | US | disclosed |
| EP-0630641-A1 | Method and dispenser for making dental products | DENTSPLY INTERNATIONAL, INC. (US) | 1994-12-28 | — | — | EP | disclosed |
| US-5320886-A | Hydrophilic crosslinking monomers and polymers made therefrom | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1994-06-14 | — | — | US | disclosed |
| US-5276068-A | Dimethacrylate compounds containing carbonate groups, adhesives, restoration material | JENERIC/PENTRON, INC. (US) | 1994-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160136059-A1 | HARDENABLE DENTAL COMPOSITION CONTAINING A MIXTURE OF AGGLOMERATED AND AGGREGATED NANO-PARTICLES, KIT OF PARTS AND USE THEREOF | NOX3, ILK, NOX1 | ALDH1A1 368/4885TSHR 3641/4885ACHE 1057/4885 |
| US-20180072691-A1 | METHODS OF PRODUCING AN HIV MATURATION INHIBITOR | TMBIM6, MCL1, FURIN | ALDH1A1 3180/4885TSHR 4829/4885ACHE 4647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.